NEW YORK, Sept. 28, 2017 -- The following statement is being issued by Levi & Korsinsky, LLP:
To: All persons or entities who purchased or otherwise acquired securities of Vitamin Shoppe, Inc. ("Vitamin Shoppe") (NYSE:VSI) between March 1, 2017 and August 8, 2017. You are hereby notified that a securities class action lawsuit has been commenced in the United States District Court for the District of New Jersey. To get more information go to:
http://www.zlk.com/plsra-c/vitamin-shoppe-inc?wire=3
or contact Joseph E. Levi, Esq. either via email at [email protected] or by telephone at (212) 363-7500, toll-free: (877) 363-5972. There is no cost or obligation to you.
The complaint alleges that throughout the class period Defendants issued materially false and/or misleading statements and/or failed to disclose that: (1) the Company's retail segment was continuing to dramatically decline, as its ongoing "reinvention plan" was not meeting with success; (2) ongoing changes to the Company's operating plan brought about through this "reinvention plan" had already rendered the more than $168 million in goodwill being carried on Vitamin Shoppe's books for the retail segment impaired and Vitamin Shoppe was improperly delaying recognizing that impairment charge; and (3) as a result of the foregoing, defendants lacked a reasonable basis for their positive statements about Vitamin Shoppe's financial prospects.
If you suffered a loss in Vitamin Shoppe you have until October 27, 2017 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.
Levi & Korsinsky is a national firm with offices in New York, California, Connecticut, and Washington D.C. The firm’s attorneys have extensive expertise and experience representing investors in securities litigation, and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
30 Broad Street - 24th Floor
New York, NY 10004
Tel: (212) 363-7500
Toll Free: (877) 363-5972
Fax: (212) 363-7171
www.zlk.com


Sam Altman Moves to Dismiss Punitive Damages in Sister's Sexual Abuse Lawsuit
Daikin Industries Stock Surges 14% After Elliott Investment Management Discloses Major Stake
Hermès Q1 2026 Sales Miss Expectations Amid Iran War and China Slowdown
DEEPX Partners with Hyundai to Power Next-Gen AI Robots Ahead of IPO
Pentagon Taps Auto Giants to Supercharge U.S. Weapons Production
SK Hynix Shares Hit Record High Amid AI Memory Demand Surge
Federal Judge Dismisses DOJ Lawsuit Attempting to Block Hawaii's Climate Case Against Oil Giants
Qantas Raises Fuel Cost Forecast Amid Middle East Oil Crisis
OpenAI's $20 Billion Cerebras Deal Signals Massive AI Infrastructure Push
Tesla's Terafab: AI Chip Factory Eyes Taiwan's Semiconductor Talent
Uber Bets Big on Autonomous Vehicles with $10 Billion Commitment
Iran War Drives Asia's Plastic Crisis — and a Green Packaging Boom
CATL Stock Hits Record High After Q1 2025 Earnings Surge
CSN's Cement Unit Sale Could Exceed $2 Billion as Global Giants Circle
Samsung Races to Deliver Next-Gen HBM4E Memory Samples to Nvidia
KKR's $820M Investment Fuels Samsung SDS AI Expansion, Sending Group Shares Soaring
Federal Agencies Secretly Test Anthropic's AI Despite Trump Administration Ban 



